Drugs / Quick-Acting Heart Reliever
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT06531161 | Aug → Sep 2024 overdue | acute mountain sickness | Peking University First Hospital | Not yet recruiting | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01513070 | Apr → Jul 2012 | coronary stenosis | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Quick-Acting Heart Reliever | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01513070 ↗ |
| Known as | Suxiao Jiuxin Pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06531161 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Suxiao Jiuxin Pill is a traditional Chinese medicine compound” NCT06531161 ↗ |
| Route | Oral | “Quick-Acting Heart Reliever，200mg，tid，po. for six months” NCT01513070 ↗ |